aTyr Pharma Selects Second IND Candidate, The First Engineered Physiocrine for GMP Process Development and for Potential Treatment of Severe Lung Diseases
Go back to aTyr Pharma Selects Second IND Candidate, The First Engineered Physiocrine for GMP Process Development and for Potential Treatment of Severe Lung Diseases| Life Technologies Corporation (NASDAQ: LIFE) | Delayed: 15.61 -1.57 (9.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.18 | 52 Week High | $10.93 | |||
| Open | $17.12 | 52 Week Low | $2.48 | |||
| Day High | $17.20 | P/E | 5.76 | |||
| Day Low | $15.33 | EPS | $2.71 | |||
| Volume | 786,147 | |||||
